The role of “watch and wait” in intestinal follicular lymphoma in rituximab era

References

• Anderson JR, Armitage JO, Weisenburger DD. Epidemiology of the non-Hodgkin’s lymphomas: distribution of the major subtypes differ by geographic locations. Non-Hodgkin’s Lymphoma Classification Project. Ann Oncol 1998;9:717–20.
   PubMed Web of Science ®Google Scholar
• Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, et al. (eds.). World health organization classification of tumours. Pathology and genetics: tumours of haematopoietic lymphoid tissues. 4th ed. Lyon: IARC Press; 2008.
   Google Scholar
• Yoshino T, Miyake K, Ichimura K, Tomohiko M, Ohara N, Hamazaki S, et al. Increased incidence of follicular lymphoma in the duodenum. Am J Surg Pathol 2000;24:688–93.
   PubMed Web of Science ®Google Scholar
• Kahl B. Is there a role for “watch and wait” in follicular lymphoma in the rituximab era? Hematology 2012;2012:433–8.
   PubMedGoogle Scholar
• Rohatiner A, d’Amore F, Coffier B, Crowther D, Gospodarowicz M, Isaacson P, et al. Report on a work shop convened to discuss the pathological and staging classifications of gastrointestinal tract lymphoma. Ann Oncol 1994;5:397–400.
   PubMed Web of Science ®Google Scholar
• Schmatz AI, Streubel B, Kretschmer-Chott E, Püspök A, Jäger U, Mannhalter C, et al. Primary follicular lymphoma of the duodenum is a distinct mucosal/submucosal variant of follicular lymphoma: a retrospective study of 63 cases. J Clin Oncol 2011;29:1445–1.
   PubMed Web of Science ®Google Scholar
• Takata K, Okada H, Ohmiya N, Nakamura S, Kitadai Y, Tari A, et al. Primary gastrointestinal follicular lymphoma involving the duodenal second portion is a distinct entity: a multicenter, retrospective analysis in Japan. Cancer Sci 2011;102:1532–6.
   PubMed Web of Science ®Google Scholar
• Tari A, Asaoku H, Kunihiro M, Tanaka S, Fujihara M, Yoshino T. Clinical features of gastrointestinal follicular lymphoma: comparison with nodal follicular lymphoma and gastrointestinal MALT lymphoma. Digestion 2011;83:191–7.
   PubMed Web of Science ®Google Scholar
• Brice P, Bastion Y, Lepage E, Brousse N, Haïoun C, Moreau P, et al. Comparison in low-tumor-burden follicular lymphomas between an initial no-treatment policy, prednimustine, or interferon alfa: a randomized study from the Groupe d’Etude des Lymphomes Folliculaires. J Clin Oncol 1997;15:1110–17.
   PubMed Web of Science ®Google Scholar
• Lewin KL, Ranchod M, Dorfman RF. Lymphomas of the gastrointestinal tract: a study of 117 cases presenting with gastrointestinal disease. Cancer 1978;42:693–707.
   PubMed Web of Science ®Google Scholar
• Herrmann R, Panahon AM, Barcos MP, Walsh D, Stutzman L. Gastrointestinal involvement in non-Hodgkin’s lymphoma. Cancer 1980;46:215–22.
   PubMed Web of Science ®Google Scholar
• Solal-Céligny P, Roy P, Colombat P, White J, Armitage JO, Arranz-Saez R, et al. Follicular lymphoma international prognostic index. Blood 2004;104:1258–65.
   PubMed Web of Science ®Google Scholar
• Taniwaki M, Ueda Y, Nishida K, Takashima T, Kashima K, Matsuda F, et al. Rapid detection of lymphoma-specific translocations in interphase nuclei of non-Hodgkin’s lymphoma by fluorescence in situ hybridization. Leukemia 1997;11:291–3.
   PubMedGoogle Scholar
• Nathwani BN, Anderson JR, Armitage JO, Cavalli F, Diebold J, Drachenberg MR, et al. Clinical significance of follicular lymphoma with monocytoid B cells. Hum Pathol 1999;30:263–8.
   PubMed Web of Science ®Google Scholar
• Tari A, Sato Y, Asaoku H, Kunihiro M, Fukumoto A, Tanaka S, et al. A duodenal follicular lymphoma associated with the lesion mimicking MALT lymphoma in terminal ileum and Bauhin valve. Med Mol Morphol 2010;43:174–7.
   PubMed Web of Science ®Google Scholar
• Yamamoto S, Nakase H, Yamashita K, Matsuura M, Takada M, Kawanami C, et al. Gastrointestinal follicular lymphoma: review of the literature. J Gastroenterol 2010;45:370–88.
   PubMed Web of Science ®Google Scholar
• Montoto S, Fitzgibbon J. Transformation of Indolent B-cell lymphomas. J Clin Oncol 2011;29:1827–34.
   PubMed Web of Science ®Google Scholar
• A Clinical Evaluation of the International Lymphoma Study Group. Classification of non-Hodgkin’s lymphoma by the non-Hodgkin’s lymphoma classification project. Blood 1997;89:3909–18.
   PubMed Web of Science ®Google Scholar
• Colombat P, Salles G, Brousse N, Eftekhari P, Soubeyran P, Delwail V, et al. Rituximab (anti-CD20 monoclonal antibody) as single first-line therapy for patients with follicular lymphoma with a low tumor burden: clinical and molecular evaluation. Blood 2001;97:101–6.
   PubMed Web of Science ®Google Scholar
• Ardeshna KM, Qian W, Smith P, Braganca N, Lowry L, Patrick P, et al. Rituximab versus a watch-and-wait approach in patients with advanced-stage, asymptomatic, non-bulky follicular lymphoma: an open-label randomized phase 3 trial. Lancet Oncol 2014;15:424–35.
   PubMed Web of Science ®Google Scholar
• Montoto S, Davies AJ, Matthews J, Calaminici M, Norton AJ, Amess J, et al. Risk and clinical implications of transformation of follicular lymphoma to diffuse large B-cell lymphoma. J Clin Oncol 2007;25:2426–33.
   PubMed Web of Science ®Google Scholar
• Link BK, Maurer MJ, Nowakowski GS, Ansell SM, Macon WR, Syrbu SI, et al. Rates and outcomes of follicular lymphoma transformation in the immunochemotherapy era: a report from the University of Iowa/Mayo Clinic specialized program of research excellence molecular epidemiology resource. J Clin Oncol 2013;31:3272–8.
   PubMed Web of Science ®Google Scholar
• Al-Tourah AJ, Gill KK, Chhanabhai M, Hoskins PJ, Klasa RJ, Savage KJ, et al. Population-based analysis of incidence and outcome of transformed non-Hodgkin’s lymphoma. J Clin Oncol 2008;26:5165–9.
   PubMed Web of Science ®Google Scholar
• Bains P, Al Tourah A, Campbell BA, Pickles T, Gascoyne RD, Connors JM, et al. Incidence of transformation to aggressive lymphoma in limited-stage follicular lymphoma treated with radiotherapy. Ann Oncol 2013;24:428–32.
   PubMed Web of Science ®Google Scholar
• Wagner-Johnston ND, Link BK, Taylor M, Bartlett NL. Risk factors for early transformation of follicular lymphoma (FL): report from the National LymphoCare Study (NLCS) [abstract]. Blood 2009;114:Abstract 2698.
   Web of Science ®Google Scholar
• Conconi A, Ponzio C, Lobetti-Bodoni C, et al. Incidence, risk factors and outcome of histological transformation in follicular lymphoma. Br J Haematol 2012;157:188–96.
   PubMed Web of Science ®Google Scholar
• Casulo C, Burack WR, Friedberg JW. Transformed follicular non-Hodgkin lymphoma. Blood 2015;125:40–7.
   PubMed Web of Science ®Google Scholar
• Gallagher CJ, Gregory WM, Jones AE, Stansfeld AG, Richards MA, Dhaliwal HS, et al. Follicular lymphoma: Prognostic factors for response and survival. J Clin Oncol 1986;4:1470–80.
   PubMed Web of Science ®Google Scholar